Marieke van Son

188 CHAPTER 10 41. Peters M, van der Voort van Zyp JRN, Moerland MA, Hoekstra CJ, van de Pol S, Westendorp H, et al. Development and internal validation of a multivari- able prediction model for biochemi- cal failure after whole-gland salvage iodine-125 prostate brachytherapy for recurrent prostate cancer. Brachyther- apy. 2016;15(3):296-305. 42. Henriquez I, Sancho G, Hervas A, Guix B, Pera J, Gutierrez C, et al. Salvage brachytherapy in prostate local re- currence after radiation therapy: pre- dicting factors for control and toxicity. Radiation oncology (London, England). 2014;9:102. 43. Spiess PE, Levy DA, Mouraviev V, Pisters LL, Jones JS. Predictors of biochemical failure in patients undergoing prostate whole-gland salvage cryotherapy: a novel risk stratification model. BJU in- ternational. 2013;112(4):E256-61. 44. Cornford P, van den Bergh RCN, Briers E, Van den Broeck T, Cumberbatch MG, De Santis M, et al. EAU-EANM-ESTRO- ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer. Eur Urol. 2020. 45. Walsh PC. Radical retropubic prosta- tectomy with reduced morbidity: an anatomic approach. NCI monographs : a publication of the National Cancer In- stitute. 1988(7):133-7. 46. Zelefsky MJ, Fuks Z, Happersett L, Lee HJ, Ling CC, Burman CM, et al. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol. 2000;55(3):241-9. 47. Avulova S, Zhao Z, Lee D, Huang LC, Koyama T, Hoffman KE, et al. The Effect of Nerve Sparing Status on Sexual and Urinary Function: 3-Year Results from the CEASAR Study. The Journal of urol- ogy. 2018;199(5):1202-9. 48. Fossati N, Di Trapani E, Gandaglia G, Dell’Oglio P, Umari P, Buffi NM, et al. Assessing the Impact of Surgeon Expe- rience on Urinary Continence Recovery After Robot-Assisted Radical Prosta- tectomy: Results of Four High-Volume Surgeons. Journal of endourology. 2017;31(9):872-7. 49. Steffens D, Thanigasalam R, Leslie S, Maneck B, Young JM, Solomon M. Ro- botic Surgery in Uro-oncology: A Sys- tematic Review and Meta-analysis of Randomized Controlled Trials. Urology. 2017;106:9-17. 50. Vernooij RWM, Cremers R, Jansen H, Somford DM, Kiemeney LA, van Andel G, et al. Urinary incontinence and erectile dysfunction in patients with localized or locally advanced prostate cancer: A nationwide observational study. Urol Oncol. 2020;38(9):735 e17- e25. 51. Schlomm T, Tennstedt P, Huxhold C, Steuber T, Salomon G, Michl U, et al. Neurovascular structure-adjacent fro- zen-section examination (NeuroSAFE) increases nerve-sparing frequency and reduces positive surgical margins in open and robot-assisted laparoscopic radical prostatectomy: experience after 11,069 consecutive patients. Eur Urol. 2012;62(2):333-40. 52. van der Slot MA, den Bakker MA, Klaver S, Kliffen M, Busstra MB, Rietbergen JBW, et al. Intraoperative assessment and re- porting of radical prostatectomy speci- mens to guide nerve-sparing surgery in prostate cancer patients (NeuroSAFE). Histopathology. 2020;77(4):539-47. 53. Dinneen E, Haider A, Allen C, Freeman A, Briggs T, Nathan S, et al. NeuroSAFE robot-assisted laparoscopic prostatec- tomy versus standard robot-assisted laparoscopic prostatectomy for men with localised prostate cancer (Neuro- SAFE PROOF): protocol for a randomised controlled feasibility study. BMJ open. 2019;9(6):e028132.